Multimodal Imaging in Ocular Toxoplasmosis

References

• Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol. 2003;136(6):973–988. doi:10.1016/j.ajo.2003.09.040.
   PubMed Web of Science ®Google Scholar
• Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965–1976. doi:10.1016/S0140-6736(04)16412-X.
   PubMed Web of Science ®Google Scholar
• Vasconcelos-Santos DV. Ocular manifestations of systemic disease: toxoplasmosis. Curr Opin Ophthalmol. 2012;23(6):543–550. doi:10.1097/ICU.0b013e328358bae5.
   PubMed Web of Science ®Google Scholar
• Ozgonul C, Besirli CG. Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res. 2017;57(1):1–12. doi:10.1159/000449169.
   PubMed Web of Science ®Google Scholar
• Maenz M, Schluter D, Liesenfeld O, et al. Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res. 2014;39:77–106. doi:10.1016/j.preteyeres.2013.12.005.
   PubMed Web of Science ®Google Scholar
• Mahendradas P, Kamath G, Mahalakshmi B, Shetty KB. Serpiginous choroiditis-like picture due to ocular toxoplasmosis. Ocul Immunol Inflamm. 2007;15(2):127–130. doi:10.1080/09273940701244202.
   PubMed Web of Science ®Google Scholar
• Pichi F, Veronese C, Lembo A, et al. New appraisals of Kyrieleis plaques: a multimodal imaging study. Br J Ophthalmol. 2016. doi:10.1136/bjophthalmol-2015-308246.
   PubMed Web of Science ®Google Scholar
• Orefice JL, Costa RA, Scott IU, et al. Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS report 1). Acta Ophthalmol. 2013;91(1):e41–7. doi:10.1111/j.1755-3768.2012.02531.x.
   PubMed Web of Science ®Google Scholar
• Gupta V, Al-Dhibi HA, Arevalo JF. Retinal imaging in uveitis. Saudi J Ophthalmol. 2014;28(2):95–103. doi:10.1016/j.sjopt.2014.02.008.
   PubMedGoogle Scholar
• Vasconcelos-Santos DV, Dodds EM, Orefice F. Review for disease of the year: differential diagnosis of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19(3):171–179. doi:10.3109/09273948.2011.581407.
   PubMed Web of Science ®Google Scholar
• Vasconcelos-Santos DV, Machado Azevedo DO, Campos WR, et al. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology. 2009;116(11):2199–205 e1. doi:10.1016/j.ophtha.2009.04.042.
   PubMed Web of Science ®Google Scholar
• Arantes TE, Silveira C, Holland GN, et al. Ocular involvement following postnatally acquired toxoplasma gondii infection in Southern Brazil: A 28-year experience. Am J Ophthalmol. 2015;159(6):1002–12 e2. doi:10.1016/j.ajo.2015.02.015.
   PubMed Web of Science ®Google Scholar
• Burnett AJ, Shortt SG, Isaac-Renton J, et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 1998;105(6):1032–1037. doi:10.1016/S0161-6420(98)96004-3.
   PubMed Web of Science ®Google Scholar
• Arevalo JF, Belfort R Jr., Muccioli C, Espinoza JV. Ocular toxoplasmosis in the developing world. Int Ophthalmol Clin. 2010;50(2):57–69. doi:10.1097/IIO.0b013e3181d26bf4.
   PubMedGoogle Scholar
• Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002;109(5):869–878. doi:10.1016/S0161-6420(02)00990-9.
   PubMed Web of Science ®Google Scholar
• Matthews JD, Weiter JJ. Outer retinal toxoplasmosis. Ophthalmology. 1988;95(7):941–946. doi:10.1016/S0161-6420(88)33071-X.
   PubMed Web of Science ®Google Scholar
• Doft BH, Gass DM. Punctate outer retinal toxoplasmosis. Arch Ophthalmol. 1985;103(9):1332–1336. doi:10.1001/archopht.1985.01050090084037.
   PubMedGoogle Scholar
• Fish RH, Hoskins JC, Kline LB. Toxoplasmosis neuroretinitis. Ophthalmology. 1993;100(8):1177–1182. doi:10.1016/S0161-6420(13)31511-5.
   PubMed Web of Science ®Google Scholar
• Banta JT, Davis JL, Lam BL. Presumed toxoplasmosic anterior optic neuropathy. Ocul Immunol Inflamm. 2002;10(3):201–211. doi:10.1076/ocii.10.3.201.15599.
   PubMed Web of Science ®Google Scholar
• Cunningham ET Jr., Munk MR, Kiss S, Zierhut M. Ultra-wide-field imaging in uveitis. Ocul Immunol Inflamm. 2019;27(3):345–348. doi:10.1080/09273948.2019.1605264.
   PubMed Web of Science ®Google Scholar
• Muftuoglu IK, Gaber R, Bartsch DU, et al. Comparison of conventional color fundus photography and multicolor imaging in choroidal or retinal lesions. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):643–649. doi:10.1007/s00417-017-3884-6.
   PubMed Web of Science ®Google Scholar
• Tan AC, Fleckenstein M, Schmitz-Valckenberg S, Holz FG. Clinical application of multicolor imaging technology. Ophthalmologica. 2016;236(1):8–18. doi:10.1159/000446857.
   PubMed Web of Science ®Google Scholar
• Schmitz-Valckenberg S, Holz FG, Bird AC, Spaide RF. Fundus autofluorescence imaging: review and perspectives. Retina. 2008;28(3):385–409. doi:10.1097/IAE.0b013e318164a907.
   PubMed Web of Science ®Google Scholar
• Brito PN, Gomes NL, Vieira MP, et al. Possible role for fundus autofluorescence as a predictive factor for visual acuity recovery after epiretinal membrane surgery. Retina. 2014;34(2):273–280. doi:10.1097/IAE.0b013e3182999a02.
   PubMed Web of Science ®Google Scholar
• Malamos P, Masaoutis P, Georgalas I, et al. The role of fundus autofluorescence imaging in the study of the course of posterior uveitis disorders. Biomed Res Int. 2015;2015:247469. doi:10.1155/2015/247469.
   PubMed Web of Science ®Google Scholar
• Durrani K, Foster CS. Fundus autofluorescence imaging in posterior uveitis. Semin Ophthalmol. 2012;27(5–6):228–235. doi:10.3109/08820538.2012.711414.
   PubMed Web of Science ®Google Scholar
• Seidensticker F, Neubauer AS, Wasfy T, et al. Wide-field fundus autofluorescence corresponds to visual fields in chorioretinitis patients. Clin Ophthalmol. 2011;5:1667–1671. doi:10.2147/OPTH.S26224.
   PubMedGoogle Scholar
• Reznicek L, Seidensticker F, Stumpf C, et al. Systematic analysis of wide-field fundus autofluorescence (FAF) imaging in posterior uveitis. Curr Eye Res. 2014;39(2):164–171. doi:10.3109/02713683.2013.834938.
   PubMed Web of Science ®Google Scholar
• Orefice J, Costa R, Scott I, et al. Multimodal fundus imaging in active ocular toxoplasmosis: blue-light fundus autofluorescence findings (Minas report 2). Invest Ophthalmol Vis Sci. 2012;53(14). https://iovs.arvojournals.org/article.aspx?articleid=2350556.
   Web of Science ®Google Scholar
• Iijima H, Tsukahara Y, Imasawa M. Angiographic findings in eyes with active ocular toxoplasmosis. Jpn J Ophthalmol. 1995;39:402–410.
   PubMed Web of Science ®Google Scholar
• Delair E, Latkany P, Noble AG, et al. Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19(2):91–102. doi:10.3109/09273948.2011.564068.
   PubMed Web of Science ®Google Scholar
• Atmaca LS, Simsek T, Atmaca Sonmez P, Sonmez K. Fluorescein and indocyanine green angiography in ocular toxoplasmosis. Graefes Arch Clin Exp Ophthalmol. 2006;244(12):1688–1691. doi:10.1007/s00417-006-0345-z.
   PubMed Web of Science ®Google Scholar
• Labriola LT, Friberg TR. Management dilemmas of atypical ocular toxoplasmosis aided by wide-field fluorescein angiography. Semin Ophthalmol. 2009;24(4–5):214–216. doi:10.1080/08820530903124201.
   Web of Science ®Google Scholar
• Balansard B, Bodaghi B, Cassoux N, et al. Necrotising retinopathies simulating acute retinal necrosis syndrome. Br J Ophthalmol. 2005;89(1):96–101. doi:10.1136/bjo.2004.042226.
   PubMed Web of Science ®Google Scholar
• Su E, Honda A, Latkany P. Chapter 5 - Ocular Disease Due to Toxoplasma Gondii. Toxoplasma Gondii. 2nd ed. Boston: Academic Press; 2014.
   Google Scholar
• Auer C, Bernasconi O, Herbort CP. Indocyanine green angiography features in toxoplasmic retinochoroiditis. Retina. 1999;19(1):22–29. doi:10.1097/00006982-199901000-00004.
   PubMed Web of Science ®Google Scholar
• Auer C, Bernasconi O, Herbort CP. Toxoplasmic retinochoroiditis: new insights provided by indocyanine green angiography. Am J Ophthalmol. 1997;123(1):131–133. doi:10.1016/S0002-9394(14)71008-6.
   PubMed Web of Science ®Google Scholar
• Bernasconi O, Auer C, Herbort CP. Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography. Ocul Immunol Inflamm. 1997;5(3):207–211. doi:10.3109/09273949709116896.
   PubMed Web of Science ®Google Scholar
• Knecht PB, Papadia M, Herbort CP. Secondary choriocapillaritis in infectious chorioretinitis. Acta Ophthalmol. 2013;91(7):e550–5. doi:10.1111/aos.2013.91.issue-7.
   PubMed Web of Science ®Google Scholar
• Khairallah M, Kahloun R, Ben Yahia S, Jelliti B. Clinical, tomographic, and angiographic findings in patients with acute toxoplasmic retinochoroiditis and associated serous retinal detachment. Ocul Immunol Inflamm. 2011;19(5):307–310. doi:10.3109/09273948.2011.602501.
   PubMed Web of Science ®Google Scholar
• Freitas-Neto CA, Cao JH, Orefice JL, et al. Increased submacular choroidal thickness in active, isolated, extramacular toxoplasmosis. Ophthalmology. 2016;123(1):222–4 e1. doi:10.1016/j.ophtha.2015.06.045.
   PubMed Web of Science ®Google Scholar
• Guex-Crosier Y, Auer C, Bernasconi O, Herbort CP. Toxoplasmic retinochoroiditis: resolution without treatment of the perilesional satellite dark dots seen by indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol. 1998;236(6):476–478. doi:10.1007/s004170050108.
   PubMed Web of Science ®Google Scholar
• Lin CJ, Chen SN, Hwang JF, Hu PS. Successful treatment of toxoplasmosis-associated choroidal neovascular lesions with bevacizumab and antiparasitic therapy. Retin Cases Brief Rep. 2011;5(4):348–351. doi:10.1097/ICB.0b013e3181ff09ae.
   PubMedGoogle Scholar
• Rouvas A, Petrou P, Douvali M, et al. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Retina. 2011;31(5):871–879. doi:10.1097/IAE.0b013e3182003ca8.
   PubMed Web of Science ®Google Scholar
• Singh M, Chee CK. Spectral domain optical coherence tomography imaging of retinal diseases in Singapore. Ophthalmic Surg Lasers Imaging. 2009;40(3):336–341. doi:10.3928/15428877-20090430-23.
   PubMedGoogle Scholar
• Mahendradas P, Madhu S, Kawali A, et al. Combined depth imaging of choroid in uveitis. J Ophthalmic Inflamm Infect. 2014;4(1):18. doi:10.1186/s12348-014-0018-8.
   PubMedGoogle Scholar
• Chen KC, Jung JJ, Engelbert M. Single acquisition of the vitreous, retina and choroid with swept-source optical coherence tomography in acute toxoplasmosis. Retin Cases Brief Rep. 2016;10(3):217–220. doi:10.1097/ICB.0000000000000230.
   PubMedGoogle Scholar
• Gallagher MJ, Yilmaz T, Cervantes-Castaneda RA, Foster CS. The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthalmol. 2007;91(12):1680–1685. doi:10.1136/bjo.2007.124099.
   PubMed Web of Science ®Google Scholar
• Garg S, Mets MB, Bearelly S, Mets R. Imaging of congenital toxoplasmosis macular scars with optical coherence tomography. Retina. 2009;29(5):631–637. doi:10.1097/IAE.0b013e318198d8de.
   PubMed Web of Science ®Google Scholar
• Cho DY, Nam W. A case of ocular toxoplasmosis imaged with spectral domain optical coherence tomography. Korean J Ophthalmol. 2012;26(1):58–60. doi:10.3341/kjo.2012.26.1.58.
   PubMedGoogle Scholar
• Orefice JL, Costa RA, Orefice F, et al. Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography. Br J Ophthalmol. 2007;91(6):773–780. doi:10.1136/bjo.2006.108068.
   PubMed Web of Science ®Google Scholar
• Kurup SP, Khan S, Gill MK. Spectral domain optical coherence tomography in the evaluation and management of infectious retinitis. Retina. 2014;34(11):2233–2241. doi:10.1097/IAE.0000000000000218.
   PubMed Web of Science ®Google Scholar
• de Souza EC, Casella AM. Clinical and tomographic features of macular punctate outer retinal toxoplasmosis. Arch Ophthalmol. 2009;127(10):1390–1394. doi:10.1001/archophthalmol.2009.251.
   PubMedGoogle Scholar
• Guagnini AP, De Potter P, Levecq L, Kozyreff A. Atypical spherical deposition on vitreoretinal interface associated with toxoplasmic chorioretinitis. Graefes Arch Clin Exp Ophthalmol. 2007;245(1):158–160. doi:10.1007/s00417-006-0330-6.
   PubMed Web of Science ®Google Scholar
• Ouyang Y, Pleyer U, Shao Q, et al. Evaluation of cystoid change phenotypes in ocular toxoplasmosis using optical coherence tomography. PLoS One. 2014;9(2):e86626. doi:10.1371/journal.pone.0086626.
   PubMed Web of Science ®Google Scholar
• Tanaka R, Obata R, Sawamura H, et al. Temporal changes in a giant macular hole formed secondary to toxoplasmic retinochoroiditis. Can J Ophthalmol. 2014;49(5):e115–8. doi:10.1016/j.jcjo.2014.06.006.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Gomez FE, Valencia M, Rodriguez F. Peripheral retinal neovascularization in recurrent cicatricial toxoplasmic retinochoroiditis: case series report. Eur J Ophthalmol. 2015;25(2):159–162. doi:10.5301/ejo.5000508.
   PubMed Web of Science ®Google Scholar
• Kianersi F, Naderi Beni A, Naderi Beni Z, Ghanbari H. Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series. Semin Ophthalmol. 2015;30(3):181–187. doi:10.3109/08820538.2013.838278.
   PubMed Web of Science ®Google Scholar
• Spaide RF, Klancnik JM Jr., Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(1):45–50. doi:10.1001/jamaophthalmol.2014.3616.
   PubMed Web of Science ®Google Scholar
• Levison AL, Baynes KM, Lowder CY, et al. Choroidal neovascularisation on optical coherence tomography angiography in punctate inner choroidopathy and multifocal choroiditis. Br J Ophthalmol. 2017;101(5):616–622. doi:10.1136/bjophthalmol-2016-308806.
   PubMed Web of Science ®Google Scholar